From Name:
From Email:
To Name:
To Email:

Optional Message:


Is pharmaceutical biotech investment at risk?

from Mike Wokasch

High profitability, strong cash positions, large global healthcare market opportunities, reliable dividends, and perceived security and stability have provided Big Pharma Biotech investors a solid basis for investment rationale. On the other hand, increasing cost of R & D, prolonged time to market, pricing pressures, marketing constraints, and regulatory uncertainty and challenges are now eroding investor confidence and interest. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063